Cargando…

Clinical Characteristics in Patients with Triple Negative Breast Cancer

PURPOSE: The purpose of this study was to compare and contrast the clinical characteristics of the triple negative breast cancer (TNBC) and non-TNBC patients, with a particular focus on genetic susceptibility and risk factors prior to diagnosis. METHODS: Our institutional database was queried for al...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Janet, Chun, Jennifer, Schwartz, Shira, Wang, Annie, Kern, Elizabeth, Guth, Amber A., Axelrod, Deborah, Shapiro, Richard, Schnabel, Freya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585655/
https://www.ncbi.nlm.nih.gov/pubmed/28912973
http://dx.doi.org/10.1155/2017/1796145
_version_ 1783261676223594496
author Yeh, Janet
Chun, Jennifer
Schwartz, Shira
Wang, Annie
Kern, Elizabeth
Guth, Amber A.
Axelrod, Deborah
Shapiro, Richard
Schnabel, Freya
author_facet Yeh, Janet
Chun, Jennifer
Schwartz, Shira
Wang, Annie
Kern, Elizabeth
Guth, Amber A.
Axelrod, Deborah
Shapiro, Richard
Schnabel, Freya
author_sort Yeh, Janet
collection PubMed
description PURPOSE: The purpose of this study was to compare and contrast the clinical characteristics of the triple negative breast cancer (TNBC) and non-TNBC patients, with a particular focus on genetic susceptibility and risk factors prior to diagnosis. METHODS: Our institutional database was queried for all patients diagnosed with invasive breast cancer between January 2010 and May 2016. RESULTS: Out of a total of 1964 patients, 190 (10%) patients had TNBC. The median age for both TNBC and non-TNBC was 59 years. There was a significantly higher proportion of African American and Asian patients with TNBC (p = 0.0003) compared to patients with non-TNBC. BRCA1 and BRCA2 were significantly associated with TNBC (p < 0.0001, p = 0.0007). A prior history of breast cancer was significantly associated with TNBC (p = 0.0003). There was no relationship observed between TNBC and a history of chemoprevention or patients who had a history of AH or LCIS. CONCLUSIONS: We found that having Asian ancestry, a prior history of breast cancer, and a BRCA1 or BRCA2 mutation all appear to be positively associated with TNBC. In order to develop more effective treatments, better surveillance, and improved prevention strategies, it is necessary to improve our understanding of the population at risk for TNBC.
format Online
Article
Text
id pubmed-5585655
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55856552017-09-14 Clinical Characteristics in Patients with Triple Negative Breast Cancer Yeh, Janet Chun, Jennifer Schwartz, Shira Wang, Annie Kern, Elizabeth Guth, Amber A. Axelrod, Deborah Shapiro, Richard Schnabel, Freya Int J Breast Cancer Research Article PURPOSE: The purpose of this study was to compare and contrast the clinical characteristics of the triple negative breast cancer (TNBC) and non-TNBC patients, with a particular focus on genetic susceptibility and risk factors prior to diagnosis. METHODS: Our institutional database was queried for all patients diagnosed with invasive breast cancer between January 2010 and May 2016. RESULTS: Out of a total of 1964 patients, 190 (10%) patients had TNBC. The median age for both TNBC and non-TNBC was 59 years. There was a significantly higher proportion of African American and Asian patients with TNBC (p = 0.0003) compared to patients with non-TNBC. BRCA1 and BRCA2 were significantly associated with TNBC (p < 0.0001, p = 0.0007). A prior history of breast cancer was significantly associated with TNBC (p = 0.0003). There was no relationship observed between TNBC and a history of chemoprevention or patients who had a history of AH or LCIS. CONCLUSIONS: We found that having Asian ancestry, a prior history of breast cancer, and a BRCA1 or BRCA2 mutation all appear to be positively associated with TNBC. In order to develop more effective treatments, better surveillance, and improved prevention strategies, it is necessary to improve our understanding of the population at risk for TNBC. Hindawi 2017 2017-08-17 /pmc/articles/PMC5585655/ /pubmed/28912973 http://dx.doi.org/10.1155/2017/1796145 Text en Copyright © 2017 Janet Yeh et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yeh, Janet
Chun, Jennifer
Schwartz, Shira
Wang, Annie
Kern, Elizabeth
Guth, Amber A.
Axelrod, Deborah
Shapiro, Richard
Schnabel, Freya
Clinical Characteristics in Patients with Triple Negative Breast Cancer
title Clinical Characteristics in Patients with Triple Negative Breast Cancer
title_full Clinical Characteristics in Patients with Triple Negative Breast Cancer
title_fullStr Clinical Characteristics in Patients with Triple Negative Breast Cancer
title_full_unstemmed Clinical Characteristics in Patients with Triple Negative Breast Cancer
title_short Clinical Characteristics in Patients with Triple Negative Breast Cancer
title_sort clinical characteristics in patients with triple negative breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585655/
https://www.ncbi.nlm.nih.gov/pubmed/28912973
http://dx.doi.org/10.1155/2017/1796145
work_keys_str_mv AT yehjanet clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT chunjennifer clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT schwartzshira clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT wangannie clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT kernelizabeth clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT guthambera clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT axelroddeborah clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT shapirorichard clinicalcharacteristicsinpatientswithtriplenegativebreastcancer
AT schnabelfreya clinicalcharacteristicsinpatientswithtriplenegativebreastcancer